2025年3月18日 · At Terumo Blood and Cell Technologies, our 7,900+ team members play an important role in the collection, processing, development, and delivery of those blood- and cell …

Today, Terumo Group’s extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, to blood transfusion and cell therapy technology, to medical products …

Terumo Blood and Cell Technologies offers a range of protocols* for the Spectra Optia device to support apheresis and cell collection needs. Browse the protocol information below for details.

Lakewood, Colorado, U.S.A. – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations …

As a global leader in therapeutic apheresis and cell collections, Terumo Blood and Cell Technologies is dedicated to advancing apheresis to help provide more treatment options for …

テルモBCT（Terumo Blood and Cell Technologies）は、テルモグループの事業の柱である3つのカンパニーのひとつ「血液・細胞テクノロジーカンパニー」を担っています。

在 Terumo BCT，希望是具体的、基于证据的，并存在于我们每个人的体内——这要归功于流经每个人体内的血液和细胞。 而这些血液对全球患者的医疗治疗至关重要。

At Terumo Blood and Cell Technologies, hope is concrete, evidence-based, and living within us all — thanks to the blood and cells that flow through every human body. And that blood is …

2025年3月6日 · ©2020 TERUMO BLOOD AND CELL TECHNOLOGIES, INC. ALL RIGHTS RESERVEDThiruvananthapuram Laboratory Scientist - KL

2025年2月21日 · Accountable for customer risk & security assessments for all Terumo Blood and Cell Technologies products (devices and software solutions). Responsible for coordinating the …